Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.85
-0.1400-4.68%
Post-market: 2.850.00000.00%16:10 EDT
Volume:347.98K
Turnover:999.63K
Market Cap:243.75M
PE:-1.43
High:2.98
Open:2.96
Low:2.81
Close:2.99
Loading ...

Atea Pharmaceuticals Inc (AVIR) Q4 2024 Earnings Call Highlights: Strategic Moves and Promising ...

GuruFocus.com
·
07 Mar

Atea Pharmaceuticals Cuts Workforce by 25%

Dow Jones
·
07 Mar

Atea Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Atea Pharmaceuticals reports Q4 EPS (40c), consensus (29c)

TIPRANKS
·
07 Mar

Atea Pharmaceuticals Q4 EPS $(0.40) Misses $(0.37) Estimate

Benzinga
·
07 Mar

BRIEF-Atea Pharmaceuticals Q4 Basic EPS USD -0.4

Reuters
·
07 Mar

Atea Pharmaceuticals Inc - Reduces Workforce by Approximately 25% in Q1 2025

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc - Expects $15 Million Cost Savings Through 2027 From Workforce Reduction

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
05 Mar

Radoff Bradley Louis - Purchased Atea Pharmaceuticals' Shares Based Belief That the Shares, When Purchased, Were Undervalued

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis Reports 3.3% Stake in Atea Pharmaceuticals as of Feb 27 - SEC Filing

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis - Intend to Nominate a Competing Slate of Candidates for Election to Atea Pharmaceuticals' Board at Upcoming Annual Meeting

THOMSON REUTERS
·
04 Mar

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025

GlobeNewswire
·
27 Feb

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
25 Feb

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

THOMSON REUTERS
·
24 Feb

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

GlobeNewswire
·
24 Feb